Article Details
Retrieved on: 2023-10-28 21:04:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The individualized neoantigen therapy mRNA-4157 (V940), combined with pembrolizumab (Keytruda), improved relapse-free survival (RFS) and distant ...
Article found on: www.oncnursingnews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here